• Patent Title: Otamixaban for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting
  • Application No.: US14424529
    Application Date: 2013-08-29
  • Publication No.: US09597322B2
    Publication Date: 2017-03-21
  • Inventor: Christophe GaudinAngèle Moryusef
  • Applicant: SANOFI
  • Applicant Address: FR Paris
  • Assignee: SANOFI
  • Current Assignee: SANOFI
  • Current Assignee Address: FR Paris
  • Agency: McDonnell Boehnen Hulbert & Berghoff
  • Priority: EP12306041 20120831
  • International Application: PCT/EP2013/067919 WO 20130829
  • International Announcement: WO2014/033221 WO 20140306
  • Main IPC: A61K31/4418
  • IPC: A61K31/4418 A61K31/4409
Otamixaban for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting
Abstract:
The invention relates to otamixaban or a pharmaceutically acceptable salt thereof for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting.
Information query
Patent Agency Ranking
0/0